Logo image of ZENA

ZENATECH INC (ZENA) Stock Fundamental Analysis

USA - NASDAQ:ZENA - CA98936T2083 - Common Stock

4.13 USD
-0.16 (-3.73%)
Last: 11/6/2025, 11:44:00 AM
Fundamental Rating

2

Taking everything into account, ZENA scores 2 out of 10 in our fundamental rating. ZENA was compared to 284 industry peers in the Software industry. The financial health of ZENA is average, but there are quite some concerns on its profitability. ZENA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

ZENA had negative earnings in the past year.
ZENA had a negative operating cash flow in the past year.
ZENA Yearly Net Income VS EBIT VS OCF VS FCFZENA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

With a Return On Assets value of -28.03%, ZENA is not doing good in the industry: 73.94% of the companies in the same industry are doing better.
ZENA has a Return On Equity of -46.52%. This is in the lower half of the industry: ZENA underperforms 67.96% of its industry peers.
Industry RankSector Rank
ROA -28.03%
ROE -46.52%
ROIC N/A
ROA(3y)-4.77%
ROA(5y)N/A
ROE(3y)-7.88%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZENA Yearly ROA, ROE, ROICZENA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

ZENA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZENA Yearly Profit, Operating, Gross MarginsZENA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -50 -100 -150 -200

5

2. Health

2.1 Basic Checks

ZENA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ZENA has more shares outstanding
Compared to 1 year ago, ZENA has an improved debt to assets ratio.
ZENA Yearly Shares OutstandingZENA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M 25M
ZENA Yearly Total Debt VS Total AssetsZENA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

ZENA has an Altman-Z score of 4.97. This indicates that ZENA is financially healthy and has little risk of bankruptcy at the moment.
ZENA's Altman-Z score of 4.97 is fine compared to the rest of the industry. ZENA outperforms 70.07% of its industry peers.
ZENA has a Debt/Equity ratio of 0.59. This is a neutral value indicating ZENA is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.59, ZENA is doing worse than 67.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z 4.97
ROIC/WACCN/A
WACC10.09%
ZENA Yearly LT Debt VS Equity VS FCFZENA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 6.78 indicates that ZENA has no problem at all paying its short term obligations.
ZENA's Current ratio of 6.78 is amongst the best of the industry. ZENA outperforms 91.90% of its industry peers.
ZENA has a Quick Ratio of 6.78. This indicates that ZENA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 6.78, ZENA belongs to the top of the industry, outperforming 91.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.78
Quick Ratio 6.78
ZENA Yearly Current Assets VS Current LiabilitesZENA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M

3

3. Growth

3.1 Past

The earnings per share for ZENA have decreased strongly by -1637.14% in the last year.
Looking at the last year, ZENA shows a small growth in Revenue. The Revenue has grown by 7.44% in the last year.
The Revenue has been decreasing by -4.94% on average over the past years.
EPS 1Y (TTM)-1637.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1207.43%
Revenue 1Y (TTM)7.44%
Revenue growth 3Y-4.94%
Revenue growth 5YN/A
Sales Q2Q%504.06%

3.2 Future

Based on estimates for the next years, ZENA will show a very negative growth in Earnings Per Share. The EPS will decrease by -72.14% on average per year.
Based on estimates for the next years, ZENA will show a very strong growth in Revenue. The Revenue will grow by 312.65% on average per year.
EPS Next Y-332.61%
EPS Next 2Y-72.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year773.44%
Revenue Next 2Y312.65%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ZENA Yearly Revenue VS EstimatesZENA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M
ZENA Yearly EPS VS EstimatesZENA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.2 -0.4 -0.6

0

4. Valuation

4.1 Price/Earnings Ratio

ZENA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ZENA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZENA Price Earnings VS Forward Price EarningsZENA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZENA Per share dataZENA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6

4.3 Compensation for Growth

A cheap valuation may be justified as ZENA's earnings are expected to decrease with -72.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-72.14%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ZENA!.
Industry RankSector Rank
Dividend Yield N/A

ZENATECH INC

NASDAQ:ZENA (11/6/2025, 11:44:00 AM)

4.13

-0.16 (-3.73%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-12 2025-08-12
Earnings (Next)11-12 2025-11-12
Inst Owners0.71%
Inst Owner Change34.07%
Ins Owners17.53%
Ins Owner ChangeN/A
Market Cap136.21M
Revenue(TTM)4.38M
Net Income(TTM)-14836100
Analysts82.86
Price Target9.18 (122.28%)
Short Float %0.88%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)-36.36%
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)65.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)45.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 43.95
P/FCF N/A
P/OCF N/A
P/B 6.03
P/tB 10.86
EV/EBITDA N/A
EPS(TTM)-0.4
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)-0.49
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS0.09
BVpS0.68
TBVpS0.38
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -28.03%
ROE -46.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.77%
ROA(5y)N/A
ROE(3y)-7.88%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 642.36%
Cap/Sales 76.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.78
Quick Ratio 6.78
Altman-Z 4.97
F-Score2
WACC10.09%
ROIC/WACCN/A
Cap/Depr(3y)356.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)44.44%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1637.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1207.43%
EPS Next Y-332.61%
EPS Next 2Y-72.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.44%
Revenue growth 3Y-4.94%
Revenue growth 5YN/A
Sales Q2Q%504.06%
Revenue Next Year773.44%
Revenue Next 2Y312.65%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1375.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-636.35%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-337.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-398.17%
OCF growth 3YN/A
OCF growth 5YN/A

ZENATECH INC / ZENA FAQ

What is the fundamental rating for ZENA stock?

ChartMill assigns a fundamental rating of 2 / 10 to ZENA.


What is the valuation status of ZENATECH INC (ZENA) stock?

ChartMill assigns a valuation rating of 0 / 10 to ZENATECH INC (ZENA). This can be considered as Overvalued.


How profitable is ZENATECH INC (ZENA) stock?

ZENATECH INC (ZENA) has a profitability rating of 0 / 10.